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Age at the onset of motor symptoms in Huntington disease (HD) is determined largely by the length of a CAG repeat expansion in HTT
but is also influenced by other genetic factors. We tested whether common genetic variation near the mutation site is associated with
differences in the distribution of expanded CAG alleles or age at the onset of motor symptoms. To define disease-associated single-nucle-
otide polymorphisms (SNPs), we compared 4p16.3 SNPs in HD subjects with population controls in a case:control strategy, which
revealed that the strongest signals occurred at a great distance from the HD mutation as a result of ‘‘synthetic association’’ with SNP
alleles that are of low frequency in population controls. Detailed analysis delineated a prominent ancestral haplotype that accounted
for ~50% of HD chromosomes and extended to at least 938 kb on about half of these. Together, the seven most abundant haplotypes
accounted for ~83% of HD chromosomes. Neither the extended shared haplotype nor the individual local HTT haplotypes were asso-
ciated with altered CAG-repeat length distribution or residual age at the onset of motor symptoms, arguing against modification of these
disease features by common cis-regulatory elements. Similarly, the 11 most frequent control haplotypes showed no trans-modifier effect
on age at the onset of motor symptoms. Our results argue against common local regulatory variation as a factor influencing HD path-
ogenesis, suggesting that geneticmodifiers be sought elsewhere in the genome. They also indicate that genome-wide association analysis
with a small number of cases can be effective for regional localization of genetic defects, even when a founder effect accounts for only
a fraction of the disorder.Introduction
Huntington disease (HD; [MIM 143100]) is a dominantly
inherited neurodegenerative disorder characterized by
involuntary movements, motor deficits, cognitive decline,
and psychiatric disturbance. The genetic defect was origi-
nally mapped to chromosome 4p16.3 by linkage to DNA
polymorphisms and then confined to a segment of ~2
Mb by crossover analysis in families.1 Further narrowing
of the candidate region was accomplished by association
analysis with both multi-allele and dimorphic DNA
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defect as an expansion mutation in the CAG trinucleotide
repeat of HTT (formerly HD [MIM 613004]) in chromo-
somal region 4p16.3.2 Not only does the length of the
HTT CAG repeat determine the probability that HD will
be manifest (alleles of 36–39 repeat units do not show
full penetrance), but it is also the primary determinant of
when these symptoms develop; when there are more
than 39 repeats, the age at onset of diagnostic motor symp-
toms decreases with increasing CAG length.2–6 Impor-
tantly, some portion of the variance in the age at onset is
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a sample of 492 HD individuals with a CAG repeat length
of 44, ~46% developed diagnostic motor symptoms at an
age that was more than 5 years earlier or later than the
average age at onset (44.4 years).7 The unexplained vari-
ance in age at onset shows heritability,8–10 supporting
the idea that genetic factors in addition to the CAG repeat
are involved in determining the age at onset of HD symp-
toms. Though genetic modifiers of HD might be located
anywhere in the genome, an attractive hypothesis is that
the chromosomal region of HTT itself harbors variation
that alters HD pathogenesis. Interestingly, even before
the expanded CAG repeat was identified, a locus closely
linked to the HD mutation was hypothesized to modify
age at onset.11 Subsequently, suggestive evidence was
reported for linkage of an age-at-onset modifier near
HTT,12 raising a potential role for the 4p16.3 haplotype
surrounding the CAG expansion as a cis-acting modifier
of the rate of disease pathogenesis leading to the onset of
motor symptoms, possibly through regulation of HTT
expression or through an effect on its protein product,
huntingtin. Similarly, a cis-acting factor affecting the
stability of the CAG repeat has also been proposed as
a factor in the disease.13 Because HD proceeds inexorably
to death an average of 16 years after the onset of motor
symptoms and because there is no preventative or attenu-
ating treatment, a mechanism capable of delaying the
onset of HD symptoms could be of great benefit. Conse-
quently, we have tested the hypothesis of a cis-acting
modifier of CAG-repeat length and/or the onset of HD
motor symptoms by evaluating the extended SNP haplo-
types of the HTT region frommutant and normal chromo-
somes. In carrying out this study, we also uncovered
‘‘synthetic association’’ signals, which we examined in
more detail in order to guide future association analyses
of HD modifiers and other disorders.Material and Methods
Subjects, SNP Genotyping, and Quality Control
DNA samples from HD subjects were collected locally or from
collaborating investigators by the Huntington’s Disease Center
Without Walls at Massachusetts General Hospital with proper
informed consent and were studied with approval of the Partners
HealthCare Institutional Review Board. SNP genotyping was
performed with the Genome-Wide Human SNPArray 6.0 (Affyme-
trix, Santa Clara CA) at the Broad Institute of MIT and Harvard
(Cambridge MA). As population controls, we used individuals
who were of European ancestry and who had been genotyped
with the same platform in a previous study but who were not
assessed for HD.14 For a stringent analysis, initial quality controls
(QCs) were applied to each cohort independently (SNP genotyp-
ing call rate > 99%; minor-allele frequency > 5%). The Hardy-
Weinberg equilibrium p value filter was applied to controls (p >
1 3 106). On the basis of high-quality SNPs that had passed
QC, we identified unrelated subjects of European ancestry by
comparing estimated identity-by-descent (IBD) calculated by the
PLINK program15 to those of HapMap samples. Subsequently,
SNPs showing significantly different call rates between HDThe Amesubjects and controls were also excluded (p < 0.001). Finally, we
obtained genotypes for 436,185 SNPs for 2,375 individuals (699
HD subjects and 1,676 controls) (sample genotyping call rate:
99.903%).Genotyping of the Delta2642 In/Del Polymorphism
We genotyped delta2642 in HD subjects by using a previously es-
tablished PCR assay with slight modifications.16 In brief, genomic
DNA (30 ng) was amplified by PCR with fluorescently labeled
primers (6-FAM-50-GCTGGGGAACAGCATCACACCC-30 and 50-
CCTGGAGTTGACTGGAGACTTG-30), then separated with an
ABI 3730 DNA analyzer (Applied Biosystems, Foster City, CA).
Subsequently, the sizes of resolved PCR products were determined
by the GeneMapper program (version 3.7) on the basis of the
internal size standards (GeneScan 500-LIZ) so that sample geno-
types could be obtained.Genome-wide Association Analysis
We performed a case-control association analysis that compared
genotypes of HD subjects (699 unrelated HD individuals) to those
of independent population controls (1,676 individuals not as-
sessed for HD) by using a chi-square test implemented in
PLINK.15 Because HD is dominantly inherited, a dominant
model was used, and SNPs with a genotype count smaller than 5
in either HD subjects or controls were excluded. We observed
significant association (p< 53 108) for multiplemarkers in chro-
mosomal region 4p16.3 and for six other SNPs (rs3754791,
rs1376313, rs4605656, rs1405178, rs1360098, and rs16928445)
not in this region. We were able to dismiss the latter as being
due to technical artifacts by performing proxy-drop association
analysis with the PLINK program. In this analysis, we excluded
and then reimputed each SNP, and we used neighboring SNPs
for the subsequent association analysis (data not shown). We
then extracted all SNPs in the 4p16.3 region of association for
further analysis.Haplotype Phasing and Analysis
Haplotype phasing of SNPs was performed with the MACH
program. 4p16.3 SNPs that showed significant association
with HD (p < 0.01) in the original dominant-model analysis
(59 SNPs) or in the dropout association analysis (21 SNPs) were
used for haplotype phasing. Among these, 21 SNPs were signifi-
cant in both analyses (Table S1, available online). In addition to
genotypes of 61 SNPs, we included genotypes of HD CAG-
repeat mutation (expanded or normal) and the delta2642 poly-
morphism (insertion or deletion) in phasing in order to identify
HD chromosomes and the major HD haplotype chromosome,
respectively, in HD subjects. The genotype of the HTT CAG
repeat in HD individuals was coded as a biallelic system, in that
each individual was a heterozygote with one expanded and one
normal allele. Among controls, each individual was coded as
a homozygote with two normal alleles of the HTT CAG repeat.
Association of haplotypes with differences in CAG length, age at
onset, or residual age at onset of motor symptoms was tested
in an ANOVA model followed by post-hoc test with Tukey’s
HSD test in R (2.7.2). Residual age at onset of motor symptoms
of an HD subject was the difference between the actual natural
log-transformed age at onset of that individual and the natural
log-transformed age at onset predicted on the basis of a large
collection of HD subjects with the same expanded HDCAG-repeat
length.7rican Journal of Human Genetics 90, 434–444, March 9, 2012 435
Figure 1. Huntington Disease Case-Control SNP Association Analysis
(A) A regional association plot focusing on the 4p16.3 region of significant association signals from HD case-control analysis is shown.
Green lines represent genes, and the light blue line shows the recombination rate (secondary y axis) based on HapMap release 22 data.
Genomic locations of SNPs and genes were based on the UCSC hg18 genome assembly. SNP rs3856973 (blue diamond) maps closest to
the HD CAG expansion mutation (inverted red triangle). SNP rs12641989 (red diamond) shows the strongest association signal (p ¼
1.73 3 1064), and the distant SNP rs11248108 (green diamond) also showed strong association with the disease (p ¼ 1.74 3 1022).
(B) To test whether rs12641989 tagged the most abundant HD haplotype and to identify SNPs associated with other haplotypes, we
compared the association signals in the original association analysis (699 HD versus 1676 controls; red trace) to those from an associ-
ation analysis (315 HD versus 1676 controls; blue trace) from which HD samples with at least one minor allele for rs12641989 had
been excluded. The location of the HTT CAG repeat is given as an inverted red triangle. Above the map are bars indicating two segments
for which detailed haplotype analysis was performed: EXT_Hap (comprising 62 markers from rs11248108 to rs12641989) and HTT_Hap
(comprising 21 markers spanning HTT) (for markers see Table S1). SNPs from the former were arbitrarily numbered sequentially from
telomeric to centromeric (e.g., 1, rs11248108; 10, rs189139; 12, rs762847; 24, rs2857845; 28, rs2285086; 34, rs11731237; 36,
rs2298969; 39, rs82333; 41, delta2642 (black triangle); 50, rs1138690; 56, rs1730768; and 62, rs12641989).Results
SNP Comparison of HD and Control Subjects
HTT maps approximately 3 Mb from the short-arm telo-
mere in the p16.3 subband of chromosome 4. As a first
step to examining the haplotype structure of HD chromo-
somes, we extracted genotypes from this region for 699
unrelated HD subjects of European origin and 1,676 popu-
lation controls.14 We generated these genotypes by using
the Affymetrix Genome-Wide Human SNP Array 6.0 plat-
form and compared them by standard case-control associ-
ation analysis (see Figure S1 for a Q-Q plot). Within an
~1 Mb region, 40 SNPs showed genome-wide significance
(dominant model, p < 5 3 108) for association with the
disorder, and most of these were centered as expected
around HTT (Figure 1A). Surprisingly, however, the SNP
most significantly associated with HD (i.e., rs12641989;
red diamond; p ¼ 1.73 3 1064) did not map to HTT but
rather mapped to RGS12 [MIM 602512], located 343 kb
proximal to the CAG expansion mutation (Figure 1A). In436 The American Journal of Human Genetics 90, 434–444, March 9addition, a group of SNPs (including rs11248108; green
diamond; p ¼ 1.74 3 1022), approximately 600 kb distal
to the CAG-expansion mutation, showed significant
association signals with HD (Figure 1A). By contrast, the
SNP closest to the CAG-expansion mutation, rs3856973
(blue diamond; p ¼ 1.87 3 1014), did not give as strong
a signal, and several SNPs within HTT gave p values
that were not significant. These results suggested that
there are multiple different mutation-bearing SNP haplo-
types in the HD population and that one or more of
these haplotypes bears SNPs that contribute to apparent
synthetic association at a considerable distance from the
HD mutation.17,18
To confirm this interpretation, we excluded HD subjects
with at least oneminor allele for rs12641989 (384 subjects)
and performed the case-control association analysis again
by using the remaining HD subjects (315 subjects) and
all controls (1676 subjects). The plot in Figure 1B shows
the results of the association analyses (dominant model)
before (red trace) and after (blue trace) the exclusion of, 2012
HD subjects with the minor allele of rs12641989 (marker
62). As expected, many SNP association signals were attrib-
utable to HD-mutation-bearing chromosomes marked by
the rs12641989 minor allele; these signals disappeared
when these HD chromosomes were excluded. Surprisingly,
among the association signals that disappeared was the
one at rs11248180 (marker 1), indicating that both
rs12641989 and rs11248180 mark an extended haplotype
of ~938 kb associated with the most abundant HD-muta-
tion-bearing chromosome. Notably, the exclusion of
HD samples on the basis of rs12641989 also generated
new genome-wide-significant association signals at
rs2857845 (marker 24) and rs1730768 (marker 56), indi-
cating that these markers tag one or more haplotypes
whose ancestral origin is likely to be different from that
of the most frequent HD haplotype. These findings are
consistent with the multi-allele-marker haplotype studies
that led originally to localization of the HD mutation
and which revealed that although the HTT region exhibits
many different haplotypes, one apparent founder haplo-
type, marked by an HTT-codon deletion polymorphism,
delta2642, was particularly frequent among HD-muta-
tion-bearing chromosomes (for convenience, here we refer
to this haplotype as the ‘‘major’’ HD haplotype).16,19
SNP-Based Haplotypes across the HTT Region
To determine the proportion of HD chromosomes bearing
the extended 938 kb haplotype detected above, we
generated SNP haplotypes (including the delta2642 codon
deletion) for 62 polymorphic sites from rs11248180
to rs12641989 (Figure 1B; Table S1). We assumed that
each individual with HD had one mutant (defined
as having >35 CAGs) and one wild-type (defined as
having <36 CAGs) allele. Fully 165 (23.6%) of the 699
HD chromosomes shared the entire 62 SNP haplotype
(Table S2), whereas only 2.1% of control chromosomes
did so, suggesting a common ancestral origin for these
HD chromosomes and preservation of an extended region
of identity by descent due to the relatively low recombina-
tion rate across this segment of 4p16.3 (Figure 1A, light
blue trace).
To test for evidence of a cis-acting modifier within this
large segment, we compared HD subjects who shared this
haplotype to those with all other HD haplotypes across
this segment. There was no significant difference in the
distribution of expanded CAG-repeat lengths, the distribu-
tion of ages at onset of diagnostic neurologic manifesta-
tions in these subjects, or the distribution of residual age
at onset after the effect of the CAG-repeat length was taken
into account (Figure 2A).
Although the extended 938 kb haplotype was readily
detectable, the even greater frequency of the delta2642
deletion allele suggested that this same ancestral chromo-
some was also the source of additional HD chromosomes
among the 699 whose shared haplotypes, as a result of
historical recombination events, were not as extended.
Consequently, we generated SNP haplotypes spanningThe AmeHTT for both HD and normal chromosomes and compared
all HD-mutation-bearing haplotypes that occurred 20 or
more times among the 699 HD chromosomes. This more
restricted haplotype of 21 markers spanned ~235 kb from
rs2857845, 48 kb upstream of HTT, to rs3095073, 17 kb
downstream (Figure 1B; Table S3). The first three SNPs
were located telomeric to the site of the CAG repeat, and
the remainder were centromeric to it.
As expected, the vast majority of chromosomes bearing
a CAG expansion could be grouped into a limited number
of HD haplotypes; ~83% of all HD chromosomes fell into
one of seven different haplotypes (Figure 3). Of these,
the most frequent, HTT_Hap_1 (which forms the core of
the shared extended haplotype noted above), accounted
for almost half of all HD-mutation-bearing chromosomes.
Most of the remaining haplotypes are likely to have arisen
from the occurrence of independent HD mutations,
although some could have been derived from HTT_Hap_1
or from one another by one or more historical recombina-
tion events within the 235 kb segment spanned by this
haplotype. For example, HTT_Hap_5, present on ~5% of
HD-mutation-bearing chromosomes, might have been
derived from HTT_Hap_1 as a result of a rare recombina-
tion event between rs2857845 and rs2471347, the ulti-
mate and penultimate SNPs on the telomeric end of the
haplotype (Figure 3B).
For each of these seven most frequent HD haplotypes,
we again examined the distribution of CAG repeat lengths
on HD-mutation-bearing chromosomes, the distribution
of ages at onset of these subjects, and the distribution of
residual age at onset after we had accounted for the effect
of the CAG-repeat length. By ANOVA, we found that the
individual HD haplotypes did not significantly influence
CAG-repeat length, age at onset, or residual of age at
onset (Figure 2B). We also compared the subjects with
HTT_Hap_1 against all other HD subjects and again found
no significant difference in any of the three parameters
(data not shown).
Thus, neither HTT nor the almost 1 Mb surrounding
region represented by the common extended HD haplo-
type showed evidence of a cis-acting modifier of either
CAG-repeat length or age at onset of motor symptoms.
Lack of HDModification by the Normal-Chromosome
HTT Region
The haplotype structure of the normal chromosome in
each HD individual also offered us the potential to test
whether the haplotype of the normal HTT allele acts as
a modifier of the age at onset of motor symptoms. We
have previously showed that the length of the HTT CAG
repeat on the normal chromosome, and by consequence
the length of the polyglutamine tract in normal hunting-
tin, does not modify the age at onset of motor symptoms
caused by mutant huntingtin.7 However, although normal
huntingtin’s polyglutamine tract does not have an impact,
it is conceivable that differences that occur in the level or
pattern of expression of the normal HTT allele and whichrican Journal of Human Genetics 90, 434–444, March 9, 2012 437
Figure 2. Local 4p16.3 Haplotype Does Not InfluenceDistribution of Either HD ExpandedCAG Repeat Length or the Age at the Onset
of Motor Symptoms
(A) The distributions of expanded CAG repeat length (top), age at the onset of motor symptoms (middle), and residual of age at the onset
of motor symptoms after the length of the CAG repeat (bottom) had been taken into account were compared for 165 individuals with an
identical extended haplotype on their HD-mutation-bearing chromosome (1: Extended haplotype 1) across the EXT_Hap segment
(Figure 1B) versus the other 424 HD subjects (Extended haplotype Other).
(B) The distributions of expanded CAG repeat length (top), age at the onset of motor symptoms (middle), and residual of age at the onset
of motor symptoms after the length of the CAG repeat (bottom) had been taken into account were compared for the seven most abun-
dant HD-mutation-bearing chromosome haplotypes, shown in Figure 3, across the HTT_Hap region (from Figure 1B).
(C) The distributions of expanded CAG repeat length (top), age at the onset of motor symptoms (middle), and residual of age at the onset
of motor symptoms after the length of the CAG repeat (bottom) had been taken into account were compared for the 11 most common
control haplotypes across the HTT_Hap region (see Figure 1B).
Each distribution is shown as a box plot, where the top, middle and bottom of the box represent the 75th percentile, median, and 25th
percentile data points, respectively. The top and bottom horizontal lines (i.e., top and bottom whiskers, connected to the box by
a vertical dashed line) represent the maximum and minimum data points, respectively, after outliers were removed by a standard inter-
quartile method (1.53 interquartile). p values of ANOVA models are shown in parentheses.are associated with differences in local haplotype might
have a modifier effect. To test this possibility, across HTT
(21 SNPs) we defined 11 haplotypes that were most
abundant on control chromosomes; each had a popula-
tion frequency of >2%. Together, these 11 haplotypes ac-
counted for ~79% of the normal chromosomes present in
the 699 HD individuals genotyped. We modeled the
residual of age at onset after accounting for the effect of
the expanded CAG repeat as a function of normal chromo-438 The American Journal of Human Genetics 90, 434–444, March 9some HTT haplotype in each individual and found no
significant evidence of disease modification (Figure 2C).
As was the case for the HD-mutation-bearing HTT haplo-
types, posthoc testing did not reveal any significant differ-
ences between individual haplotypes (data not shown).
Thus, as with the HTT region of HD-mutation-bearing
chromosomes, the HTT region of at least the majority of
normal chromosomes does not act as a modifier of the
age at the onset of motor symptoms in HD., 2012
Figure 3. Haplotypes across HTT
(A) The relative frequencies of eachHTT_Hap amongHD-mutation-bearing chromosomes (top) and control subjects (bottom) are shown
in pie charts.
(B) The sevenmost frequent haplotypes acrossHTTon HD-mutation-bearing chromosomes are shown, with the name and allele of each
of 21 markers (20 SNPs and 1 in/del). Also given are the frequencies of these haplotypes on HD-mutation-bearing and control chromo-
somes and the location of the HTT CAG repeat (red line).Underlying Mechanisms of Synthetic Association
in the HD-Control GWAS
As noted above, the overall case-control association anal-
ysis was remarkable for yielding the most-significant asso-
ciation signals at a considerable physical distance from
HTT. Because the causal mutation located in exon 1 of
HTT is well established,2 our data provide a rare opportu-
nity for investigating the underlying mechanisms of such
synthetic association in an actual experimental dataset. It
was evident from the haplotype analyses that the minor
alleles for rs12641989 (A) in RGS12 and rs11248108 (A)
in RNF4 (MIM 602850) were both overrepresented in the
HD cohort. In the case of the latter marker, this overrepre-
sentation was a result of its presence on the 165 major HD
haplotype chromosomes with the 938 kb shared extended
haplotype; in the case of the former marker, the overrepre-
sentation was a result of its presence on the majority of the
330 HD chromosomes that bear HTT_Hap_1, all of which
also have the delta2642 deletion allele. However, none of
the SNP markers in HTT itself yielded scores as highly
significant as these distant markers. Clearly, the relative
significance of the SNPs did not correlate with their phys-
ical distance from the causal variation (Figure S2A), but as
expected, it did correlate strongly with the difference in
allele frequency between cases and controls (Figure S2B).
Although for these markers the absolute difference in
minor-allele frequency between cases and controls was
slightly correlated with distance from the expanded CAG
(Figure S2C), we observed a much stronger correlation
between control minor-allele frequency and associationThe Amesignificance (Figure S2D). On the basis of these observa-
tions, we hypothesized that the synthetic association
signals in the HD case-control GWAS were created by
a combination of the existence of an extended version of
an ancestral major haplotype represented by HTT_Hap1
(and probably HTT_Hap5) and the presence on chromo-
somes with that haplotype of minor alleles for some SNP
markers that show low minor-allele frequency in controls.
To test this hypothesis, we investigated the relationship
between control minor-allele frequencies and the signifi-
cance of the association signals across the region. In order
to discern patterns of recombination across the region as
reflected in the major HD haplotype (Figure 4A), we used
those SNPs whose minor alleles were significantly overrep-
resented in HD subjects as compared to controls (p < 0.05
in the original association analysis). We calculated the
minor-allele frequency in controls (black) and the
frequency of the same allele in HD subjects (red), in HD
subjects with the minor (deletion) allele for delta2642
(green), and on HD-mutation-bearing chromosomes with
the minor allele for delta2642 (blue). Grouping in this
way provided a gradual enrichment for HD-mutation-
bearing chromosomes with the major HD haplotype. For
example, ~25.8% of all chromosomes in HD subjects
(red), ~50% of all chromosomes in those HD subjects
with a delta2642 deletion (green), and close to 100% of
HD chromosomes that themselves had a delta2642 dele-
tion (blue) represented this haplotype. As shown in
Figure 4A, allele frequencies for all SNP minor alleles,
except rs2857845, rs363082, and rs1730768 (arrows),rican Journal of Human Genetics 90, 434–444, March 9, 2012 439
Figure 4. Effect of Allele Frequency in Controls and Recombination on Significance in Association Analysis
To test whether allele frequency in controls plays an important role in determining significance in association analysis, we analyzed data
sets that were progressively enriched for the HD major haplotype.
(A) For eachmarker, the allele frequency of that allele which is minor in the control population was plotted against its genomic location
in the following groups: (1) all controls (1676 controls; black), (2) all cases (699 HD subjects; red), (3) cases with at least one delta2642
deletion allele (384 HD subjects; green), and (4) HDmutation-bearing chromosomes with a delta2642 deletion allele (362 chromosomes;
blue). To simplify the analysis, we show those SNPs whoseminor allele was overrepresented in HD subjects versus controls in the original
association analysis (p < 0.05; 41 SNPs). The boundaries of ‘‘nonrecombination’’ (blue) and ‘‘mild recombination’’ (red) zones represent
arbitrary cut-offs (80% and 50%, respectively) based on allele frequency on HD-mutation-bearing chromosomes.
(B) Association analyses were performed for all SNPs in the nonrecombination zone; each of the enrichment groups from (A) was
compared to controls (allele test). The significance of the apparent HD risk alleles (overrepresented in HD compared to controls; p <
0.05 in the original dominant model association analysis involving all HD subjects and controls) (y axis) was plotted against the corre-
sponding allele frequency in controls (x axis).
(C) Association analyses were performed for all SNPs in the mild recombination zone; each of the enrichment groups from (A) was
compared to controls (allele test). The significance of the apparent HD risk alleles (y axis) was plotted against the corresponding allele
frequency in controls (x axis).
(D) To eliminate the effect of recombination, we performed an association analysis (allele test) by comparing allele frequencies of all SNPs
on the HD-mutation-bearing chromosomes with Ext_Hap_1 to their allele frequencies on control chromosomes. Significance (y axis)
was plotted against frequency of apparent risk allele (x axis).increased as the major HD haplotype was enriched (red to
green to blue); this is consistent with our haplotyping
results, which indicated that rs2857845, rs363082 and
rs1730768 tag other haplotypes.
On the basis of the apparent decay in the major HD
haplotype (i.e., Figure 4A, blue trace, excluding rs363082),
we arbitrarily divided the chromosome 4p region into
a relative ‘‘nonrecombination’’ zone (control minor allele
present on >80% of HD major haplotype chromosomes;
blue bar) and a relative ‘‘mild recombination’’ zone (control
minor allele present on >50% but <80% of HD major-
haplotype chromosomes; red bars). In both zones, we
then tested SNP markers within each of the haplotype-440 The American Journal of Human Genetics 90, 434–444, March 9enrichment groups separately for an association with HD.
We tested the following groups: (1) all controls versus
all cases (red); (2) all controls versus only those cases
with a delta2642 deletion allele (green); and (3) all control
chromosomes versus only those chromosomes bearing
a HD mutation and having a delta2642 deletion allele
(blue) (Figures 4B and 4C). In the nonrecombination
zone (118 kb), we observed a strong negative correlation
between the frequency of a SNP’s apparent risk allele
(i.e., the allele increased in HD subjects) in controls and
the significance of association with that SNP. The correla-
tion became progressively stronger as the sample was en-
riched for the major HD haplotype (red to green to blue),, 2012
supporting the notion that the control allele frequency
plays an important role in creating synthetic associations
(Figure 4B). In the mild recombination zone (938 kb,
excluding the 118 kb nonrecombination zone), we used
only SNPs that showed nominally significant differences
between HD subjects and controls in the original associa-
tion analysis (dominant-model p value < 0.05) because
inclusion of nonsignificant SNPs would add noise to the
analysis and complicate interpretation. Similarly to the
nonrecombination region findings, we observed a negative
correlation between control minor-allele frequency and
association significance, although the significance values
were considerably lower than those achieved in the nonre-
combination zone at a similar control allele frequency, sug-
gesting a strong effect of recombinational decay of the
major HD haplotype (Figure 4C). Taken together, these
results imply that the control minor-allele frequency and
the recombination frequency, rather thanphysical distance
between the SNP and the causative defect, play important
roles in determining synthetic associations.
To confirm this conclusion, we compared the subset of
major-haplotype HD chromosomes that shared the entire
extended haplotype of 938 kb from rs11248108 to
rs12641989 to control chromosomes. This permitted us
to compare the strength of association across SNPs without
encountering any effect of recombination. As shown in
Figure 4D, markers across this segment showed a smooth
inverse relationship between the strength of association
and allele frequency on control chromosomes, confirming
the notion that control minor-allele frequency plays a crit-
ical role in synthetic associations. Together, our results
strongly indicate that synthetic association signals in HD
were contributed by a combination of a frequent, extended
HD haplotype in cases and the inclusion of markers with
relatively low minor-allele frequencies in the genotyping
array of controls.Discussion
The results of the case-control SNP association analysis of
HD and the subsequent HTT-region haplotype analysis
that we performed here, taken in historical context, have
implications for applying the approach to chromosomal
localization and identification of other strong-effect
human genetic defects. The approach might be particu-
larly useful for relatively rare phenotypes that result in
small family sizes, which preclude effective linkage anal-
ysis, and for founder mutations that contribute only
a subset of cases for a phenotype of diverse etiology. The
genetic defect causing HD was identified almost two
decades ago when our knowledge of human genetic varia-
tion was far less evolved and the technologies for perform-
ing human genetic studies were far less powerful than they
are today. Its identification came after genetic linkage
mapping, first with restriction-fragment length polymor-
phisms, and subsequently with PCR-based multi-alleleThe Amemarkers, in HD-affected families confined the disease
mutation to a region of 2.2 Mb in 4p16.3.1,20 This candi-
date region was then narrowed by association analysis, in
which the biallelic markers presented the apparent quan-
dary of closely spaced polymorphisms that alternatively
showed either strong or no evidence for association.
The conundrum was explained by the power of the multi-
allele markers to resolve multiple ancestral haplotypes,
a particularly frequent one of which was marked by the
minor deletion allele of a 3 bp in/del polymorphism
(delta2642) that ultimately proved to represent a codon
in HTT.16,19,21 The comparison of markers on HD chromo-
somes bearing this minor allele focused the search for the
genetic defect to a 150 kb segment with the HTT CAG
repeat and led to its identification.
Not unexpectedly, the data generated from our current
analysis indicate that a case-control genome-wide SNP-
association approach could have quickly accomplished
the initial mapping of the HD genetic defect to 4p16.3
and that it could have done so with as few as 50 unrelated
HD cases and 1,600 controls, despite the presence of
multiple founder chromosomes. However, the analysis of
individual SNPs would not have finely localized the CAG
mutation; the most significantly associated marker is in
RGS12, 343 kb from the defect. It should also be noted
that application of current whole-exome or even whole-
genome next-generation sequencing strategies would
not have identified the HD mutation because sizing even
longer normal alleles is problematic with short-read tech-
nologies. Thus, like the multi-allele-marker haplotype
analysis that actually led to the identification of the
expanded CAG repeat, SNP-based haplotype analysis
would have been required to home in on the defect after
the initial association analysis placed it in region 4p16.3.
rs12641989 yielded the strongest association signal
because it was present on the most frequent ancestral HD
haplotype, it had a low minor-allele frequency in the
control population, there was a low recombination rate
across this region, and this low recombination rate allowed
an extended shared haplotype. Our data strongly suggest
that SNP arrays aimed at genotyping markers with even
lower control minor-allele frequencies would be yet more
powerful for initial chromosomal localization of founder
mutations. However, because a defect localized by associa-
tion with a rare allele might be at a considerable physical
distance from the marker, subsequent identification of
the actual defect could benefit from detailed haplotype
analysis that takes into account the local recombination
landscape. The same argument can be made for pheno-
typic associations linked to genomic segments introduced
into a population by admixture or to phenotypes where
only a minor proportion of cases are due to a founder
mutation. Indeed, case-control simulations indicate that
for a SNP with a control minor-allele frequency of 0.01,
a founder haplotype bearing such an allele need be present
in less than 60 cases in 1,000 or 100 cases in 5,000 to yield
genome-wide significance (p < 5 3 108; Figure S3).rican Journal of Human Genetics 90, 434–444, March 9, 2012 441
Our SNP haplotype analysis of the HTT region, which
extends previous lower-resolution investigations, is
revealing with regard to the structure of the HD popula-
tion. The studies that led to the identification of the
CAG expansion mutation investigated only 78 HD chro-
mosomes without regard to population ancestry and iden-
tified 26 different haplotypes, although these involved
markers widely dispersed over the large 2.5 Mb HD candi-
date region then defined by recombination events in
families. There was far less diversity in the immediate
region of the mutation: Approximately one-third of chro-
mosomes shared a common set of alleles, including the
deletion allele at HTT codon 2642. More recently, Warby
et al.13 identified 22 HTT SNPs that permitted the defini-
tion of a haplogroup representing 95% of 268 HD Euro-
pean chromosomes. However, their analysis allowed for
diversity at many additional intervening SNPs within
HTT, indicating that this single haplogroup combines
multiple HTT haplotypes. Though the analysis here was
also restricted to individuals of European ancestry, the
delineation of multiple dense SNP haplotypes spanning
the HD mutation is most consistent with multiple inde-
pendent origins of the HD-mutation-bearing chromo-
somes in this population.
The seven most abundant HTT-region haplotypes
constituted 582 of the 699 chromosomes, whereas the re-
maining 117 HD-mutation-bearing chromosomes ac-
counted for 48 additional haplotypes (HTT_Hap_Other).
Although many of these haplotypes, such as HTT_Hap_1
and HTT_Hap_5, might be derived from one another
by historical crossovers, it seems likely that there have
been a minimum of four founder events given that there
are HD-mutation-bearing chromosomes representing all
four two-marker haplotypes for SNPs rs2798296 and
rs3856973, which flank the CAG repeat (A-A, four in
HTT_Hap_Other; A-G, HTT_Hap_3 and ten in HTT_Hap_
Other; G-A, HTT_Hap_4 and three in HTT_Hap_Other;
G-G, HTT_Hap_1, HTT_Hap_2, HTT_Hap_5, HTT_Hap_6,
HTT_Hap_7, and 31 in HTT_Hap_Other).
Despite this diversity, one founder event accounts
for about half of all these European HD chromosomes
(HTT_Hap_1 and probably the derivative HTT_Hap_5). It
corresponds with the most frequent HD haplotype defined
in earlier studies given that it is marked by the delta2642
deletion allele. Of the most frequent HD haplotypes,
HTT_Hap_2 and HTT_Hap_3 show little or no increase
in frequency relative to control chromosomes, whereas
HTT_Hap_1 shows an increase of more than 5-fold. Inter-
estingly, almost 50% of the HTT_Hap_1 HD-mutation-
bearing chromosomes share an identical SNP haplotype
that reaches far beyond the confines of HTT and extends
over at least 938 kb, reflecting the relatively low recombi-
nation rate across this segment and reinforcing the view
that many of the other observed haplotypes represent
independently originating HD mutations. This pattern
also fits predictions that are based on the analysis of repro-
ductive success in HD.22442 The American Journal of Human Genetics 90, 434–444, March 9Delineation of the haplotype structure of the 4p16.3
segment has permitted us to test for cis-acting modifiers
of HD pathogenesis. For the seven most abundant HTT
haplotypes, we observed no significant difference in the
distribution of expanded CAG repeats, indicating that at
least for the substantial majority of HD chromosomes,
there is no evident effect of local variation on the insta-
bility of the expanded CAG repeat. Previous analysis sug-
gested enrichment of a particular haplogroup on both
HD chromosomes and control chromosomes with CAG
repeats high in the normal range, raising the possibility
that this haplogroup is predisposed to instability.13 The
low frequency of this haplogroup among East Asians has
been proposed as the basis for the lower prevalence of
HD in this population relative to Europeans.23 Our data
are not directly comparable to the haplogroup analyses,
but the lack of an effect of local haplotype on instability
within the expanded CAG allele range does not preclude
an effect within the high normal HD range. Similarly,
although we cannot speak to the CAG allele distribution
on the control chromosomes used here, it is likely that
the HD_Hap_1 haplotype in the normal population is asso-
ciated with higher-range normal alleles that act as a reser-
voir of new mutations to HD because such high normal
alleles might be more likely to expand into the HD range.
Indeed, we have previously noted that the major haplo-
type defined by the delta2642 deletion allele marks chro-
mosomes that gave rise to sporadic cases of HD in ‘‘new
mutation’’ families, indicating that the current pool of
HTT_Hap_1 HD cases is descended from multiple normal
individuals who transmitted a newly expanded allele on
this haplotype.24
The detailed haplotype analysis also provided the basis
for testing the hypothesis that local genetic variation
modifies HD pathogenesis through either a cis- or a trans-
acting effect on HTT expression. Neither the extended
shared haplotype nor the seven most abundant HTT
haplotypes on HD-mutation-bearing chromosomes
showed evidence of influencing age at the onset of motor
symptoms after the effect of the expanded CAG repeat
length, which is the main driver of pathogenesis, was
taken into account. Similarly, the HTT haplotypes on the
normal chromosomes present in HD subjects showed no
evidence of an impact on the age at onset, consistent with
the previous finding that neither the length of the normal
CAG allele nor the presence of a second expanded CAG
allele has a significant impact on the rate of pathogenesis
leading to the onset of motor symptoms.7 Although it
is conceivable that the local HTT haplotype might still
influence some other HD phenotype, the age at the onset
of motor symptoms correlates strongly with the length of
the expanded CAG allele and shows evidence of being
altered by one or more modifier genes.
Our study also does not exclude the possibility that one
or more rare haplotypes among the HD_Hap_Other
grouping does involve a cis-modifier effect on either CAG
repeat instability or the age at the onset of motor, 2012
symptoms or that a rare <2% frequency control haplotype
might exert a trans effect. However, our findings do indi-
cate that no such effects occur in most HD subjects, and
they suggest instead that the emphasis should be on iden-
tifying trans-acting modifiers located elsewhere in the
genome. The ability to attribute the full effect of the HTT
locus to the length of the expanded CAG repeat, without
having to consider other genetic variation at the locus,
will facilitate the analysis of genome-wide association
scans aimed at identifying such modifier genes; such anal-
ysis is a high priority in HD because valid targets for ther-
apeutic intervention are badly needed.Supplemental Data
Supplemental Data include three figures and three tables and can
be found with this article online at http://www.cell.com/AJHG.Acknowledgments
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